MYCN and neuroblastoma: While all MNA-NB are classified as high-risk neuroblastomas, there is still a lack of treatment options that directly target MYCN due to an insufficient understanding of the structure of the N-Myc protein (Bell et al., 2010; Wolpaw et al., 2021).